The Effect of Aclidinium on Symptoms Including Cough in Chronic Obstructive Pulmonary Disease: A Phase 4, Double-Blind, Placebo-controlled, Parallel-Group Study

Pulmonary Disease ◽

Chronic Obstructive ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group Study ◽

A 28-day, randomized, double-blind, placebo-controlled, parallel group study of nebulized revefenacin in patients with chronic obstructive pulmonary disease

Respiratory Research ◽

10.1186/s12931-017-0647-1 ◽

2017 ◽

Vol 18 (1) ◽

Cited By ~ 16

Author(s):

Krishna K. Pudi ◽

Chris N. Barnes ◽

Edmund J. Moran ◽

Brett Haumann ◽

Edward Kerwin

Keyword(s):

Pulmonary Disease ◽

Chronic Obstructive ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group Study ◽

Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(13)70052-3 ◽

2013 ◽

Vol 1 (3) ◽

pp. 199-209 ◽

Cited By ~ 284

Author(s):

Jadwiga A Wedzicha ◽

Marc Decramer ◽

Joachim H Ficker ◽

Dennis E Niewoehner ◽

Thomas Sandström ◽

...

Keyword(s):

Pulmonary Disease ◽

Chronic Obstructive ◽

Double Blind ◽

Parallel Group Study ◽

Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol–fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(12)70052-8 ◽

2013 ◽

Vol 1 (1) ◽

pp. 51-60 ◽

Cited By ~ 173

Author(s):

Claus F Vogelmeier ◽

Eric D Bateman ◽

John Pallante ◽

Vijay KT Alagappan ◽

Peter D'Andrea ◽

...

Keyword(s):

Pulmonary Disease ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Double Blind ◽

Once Daily ◽

Parallel Group Study ◽

The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: An eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study

Clinical Therapeutics ◽

10.1016/j.clinthera.2005.05.009 ◽

2005 ◽

Vol 27 (5) ◽

pp. 531-542 ◽

Cited By ~ 19

Author(s):

Barry Make ◽

Nicola A. Hanania ◽

Richard ZuWallack ◽

Christopher Kalberg ◽

Amanda Emmett ◽

...

Keyword(s):

Fluticasone Propionate ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Double Blind ◽

Parallel Group Study ◽

T5 Oral dietary nitrate supplementation to enhance pulmonary rehabilitation in chronic obstructive pulmonary disease: a multi-centre, double blind, placebo-controlled, parallel group study

10.1136/thorax-2018-212555.5 ◽

2018 ◽

Author(s):

MJ Pavitt ◽

RJ Tanner ◽

AP Lewis ◽

SC Buttery ◽

B Mehta ◽

...

Keyword(s):

Pulmonary Disease ◽

Pulmonary Rehabilitation ◽

Chronic Obstructive ◽

Double Blind ◽

Dietary Nitrate ◽

Double Blind Placebo ◽

Parallel Group ◽

Nitrate Supplementation

Faculty Opinions recommendation of Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718313352.793493922 ◽

2014 ◽

Author(s):

Mark Dransfield ◽

Michael Wells ◽

Surya Bhatt

Keyword(s):

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Double Blind ◽

Double Blind Placebo

Faculty Opinions recommendation of Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718348198.793494105 ◽

2014 ◽

Author(s):

Adam Wanner ◽

Timothy Scialla

Keyword(s):

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Double Blind ◽

Sugarcane bagasse dietary fiber as an adjuvant therapy for stable chronic obstructive pulmonary disease: a four-center, randomized, double-blind, placebo-controlled study

Journal of Traditional Chinese Medicine ◽

10.1016/s0254-6272(16)30057-7 ◽

2016 ◽

Vol 36 (4) ◽

pp. 418-426 ◽

Cited By ~ 1

Author(s):

Liu Miao ◽

Zheng Fengjie ◽

Ni Lei ◽

Sun Yan ◽

Wu Ruohan ◽

...

Keyword(s):

Adjuvant Therapy ◽

Dietary Fiber ◽

Pulmonary Disease ◽

Sugarcane Bagasse ◽

Controlled Study ◽

Chronic Obstructive ◽

Double Blind ◽

Double Blind Placebo

Supplemental dietary nitrate for chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled, crossover trial

Proceedings of The Nutrition Society ◽

10.1017/s0029665113001705 ◽

2013 ◽

Vol 72 (OCE3) ◽

Cited By ~ 1

Author(s):

C. P. Kerley ◽

K. Cahill ◽

K. Bolger ◽

K. Fennell ◽

A. O'Brien ◽

...

Keyword(s):

Pulmonary Disease ◽

Crossover Trial ◽

Chronic Obstructive ◽

Double Blind ◽

Dietary Nitrate ◽

Double Blind Placebo

Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(13)70200-5 ◽

2014 ◽

Vol 2 (1) ◽

pp. 63-72 ◽

Cited By ~ 51

Author(s):

Henrik Watz ◽

Helen Barnacle ◽

Benjamin F Hartley ◽

Robert Chan

Keyword(s):

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

P38 Mapk Inhibitor ◽

Mapk Inhibitor